Aradhana M. Venkatesan

ORCID: 0000-0002-5033-0820
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Peptidase Inhibition and Analysis
  • Cancer Immunotherapy and Biomarkers
  • Radiomics and Machine Learning in Medical Imaging
  • Bladder and Urothelial Cancer Treatments
  • Endometrial and Cervical Cancer Treatments
  • Renal cell carcinoma treatment
  • Prostate Cancer Diagnosis and Treatment
  • Adenosine and Purinergic Signaling
  • MRI in cancer diagnosis
  • Advanced Breast Cancer Therapies
  • Ovarian cancer diagnosis and treatment
  • Medical Imaging Techniques and Applications
  • Advanced MRI Techniques and Applications
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Uterine Myomas and Treatments
  • Cancer Genomics and Diagnostics
  • Renal and related cancers
  • Adrenal and Paraganglionic Tumors
  • Cancer, Hypoxia, and Metabolism
  • Cervical Cancer and HPV Research
  • Radiation Dose and Imaging
  • Pancreatic and Hepatic Oncology Research
  • Prostate Cancer Treatment and Research
  • Advanced X-ray and CT Imaging

The University of Texas MD Anderson Cancer Center
2016-2025

University of Iowa Hospitals and Clinics
2024

University of Iowa Health Care
2024

Agostino Gemelli University Polyclinic
2024

National Institutes of Health
2008-2023

National Institute of Arthritis and Musculoskeletal and Skin Diseases
2023

Scripps MD Anderson Cancer Center
2023

The University of Texas Health Science Center at Houston
2019-2020

Piedmont Atlanta Hospital
2020

Mayo Clinic in Arizona
2019

P-glycoprotein (Pgp) antagonists have been difficult to develop because of complex pharmacokinetic interactions and a failure show meaningful results. Here we report the results pharmacodynamic trial using third-generation, potent, noncompetitive inhibitor Pgp, tariquidar (XR9576), in combination with docetaxel.

10.1158/1078-0432.ccr-10-1725 article EN Clinical Cancer Research 2010-11-17

Background In this multicenter, single‐arm, multicohort, phase 2 trial, the efficacy of nivolumab and ipilimumab was evaluated in patients with advanced rare genitourinary cancers, including bladder upper tract carcinoma variant histology (BUTCVH), adrenal tumors, platinum‐refractory germ cell penile carcinoma, prostate cancer (NCT03333616). Methods Patients malignancies no prior immune checkpoint inhibitor exposure were enrolled. received at 3 mg/kg 1 intravenously every weeks for 4 doses,...

10.1002/cncr.33328 article EN Cancer 2020-11-20

To assess the feasibility of combined electromagnetic device tracking and computed tomography (CT)/ultrasonography (US)/fluorine 18 fluorodeoxyglucose (FDG) positron emission (PET) fusion for real-time feedback during percutaneous intraoperative biopsies hepatic radiofrequency (RF) ablation.In this HIPAA-compliant, institutional review board-approved prospective study with written informed consent, 25 patients (17 men, eight women) underwent 33 three 36 FDG-avid targets between November 2007...

10.1148/radiol.11101985 article EN Radiology 2011-07-07

Context:Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis in need of more effective treatment options. Published evidence indicates many ACCs express the vascular endothelial growth factor receptor (VEGFR), suggesting inhibiting signaling could potentially impact tumor growth.

10.1210/jc.2013-2298 article EN cc-by The Journal of Clinical Endocrinology & Metabolism 2014-01-14

Liver abscesses in chronic granulomatous disease (CGD) are typically difficult to treat and often require surgery. We describe 9 X-linked CGD patients with staphylococcal liver refractory conventional therapy successfully treated corticosteroids antibiotics. Corticosteroids may have a role treatment of Staphylococcus aureus CGD.

10.1093/cid/cir896 article EN Clinical Infectious Diseases 2011-12-09
Coming Soon ...